Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Head and Neck Neoplasms 3 Polycystic Ovary Syndrome 2 Pain 2 Neoplasms 2 Endocrine System Diseases 2 Amenorrhea 2 Trismus 1 Thrombosis 1 Neuroma 1 Movement Disorders 1 Motor Activity 1 Lymphedema 1 Health Education 1 Fibrosis 1 Deglutition Disorders 1 Anxiety Disorders 1 Agnosia 1

Interventions

Radiotherapy 3 Cisplatin 3 Exercise 2 Deglutition 2 Cryotherapy 2 Carboplatin 2 Brachytherapy 2 Acupuncture Therapy 2 tislelizumab 1 pembrolizumab 1 epigallocatechin gallate 1 durvalumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tablets 1 Standard of Care 1 Respiratory Function Tests 1 Resistance Training 1 Range of Motion, Articular 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Pravastatin 1 Parenteral Nutrition 1 Paclitaxel 1 Nivolumab 1 Niacinamide 1 Musculoskeletal Manipulations 1 Lead 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Deglutition Disorders × Musculoskeletal Manipulations × Clear all

NCT03612531 2026-04-23

MANTLE

M.D. Anderson Cancer Center

Phase NA Active not recruiting

Deglutition Disorders, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡